By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
PR Newswire SAN DIEGO, April 9, 2025 SAN DIEGO, April 9, 2025 /PRNewswire/ -- Long COVID or post COVID-19 syndrome, is a clinical entity observed in certain patients wherein symptoms of illness persist for at least several weeks or months ...
PR Newswire PRINCETON, N.J., March 25, 2025 Broader protection induced by combination of COVID adenovirus vaccine plus CiVax™ compared to 2-shot mRNA vaccination series PRINCETON, N.J., March 25, 2025 /PRNewswire/ -- Soligenix, Inc. ...
PR Newswire PLYMOUTH MEETING, Pa., March 13, 2025 PLYMOUTH MEETING, Pa., March 13, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people ...
PR Newswire LA JOLLA, Calif., March 4, 2025 62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated with Auxora versus placebo in subset of patients in CARDEA with AKI LA JOLLA, Calif., March ...
PR Newswire WASHINGTON, Feb. 24, 2025 The study examines the use and efficacy of at-home COVID-19 testing. WASHINGTON, Feb. 24, 2025 /PRNewswire/ -- UMass Chan Medical School is partnering with Curai Health to provide virtual care to ...
PR Newswire SALT LAKE CITY, Feb. 21, 2025 The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. ...
PR Newswire SAN ANTONIO, Jan. 22, 2025 A nationwide RECOVER study led by The University of Texas Health Science Center at San Antonio, funded by the National Institutes of Health, finds that females have a 31% higher associated risk of long ...
PR Newswire WASHINGTON, Jan. 17, 2025 A federal lawsuit filed this week alleges that the Secretary of Health and Human Services (HHS) has failed to meet the deadline required by federal law to include the COVID-19 vaccine in the National ...
PR Newswire HUNTINGTON, N.Y., Jan. 15, 2025 HUNTINGTON, N.Y., Jan. 15, 2025 /PRNewswire/ -- Sen-Jam Pharmaceutical is excited to announce the preliminary results from its recently completed Phase 2 clinical trial evaluating the safety and ...
PR Newswire SEOUL, South Korea, Jan. 8, 2025 SEOUL, South Korea, Jan. 8, 2025 /PRNewswire/ -- The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid ...
White blood cell counts or leukocytes could be a crucial indicator of COVID-19 severity in women, impacting treatment strategies, stated new research.
Nearly 70% of patients report lingering symptoms of Long-COVID, highlighting its widespread impact and need for ongoing research and care solutions.
Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from animals to humans.
AI reveals hidden care needs in Long COVID patients, helping physicians offer targeted treatments and improve patient outcomes with personalized care strategies.
Human Metapneumovirus (HMPV) is causing respiratory issues in China, with flu-like symptoms, spreading through droplets. Precautionary measures include hygiene and masks.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers